Heads Up! Big News on Stem Cells & Covid This Weekend.

Gentlemen Start Your Research Engines! Be Fast and Be Early. We Could be Looking at a "Beam Me Up Scotty" Type Vector - Pulling...
Organicell

Corona Craziness Continues. Organicell (BPSR) Gains 10-fold or 1000%, in Six Weeks.

Too bad we don't trade for a living! We don't even use real-time quotes, LOL. $0.02 to $0.27, from Easter - what HOOT-N-HOLLER. LIVE CHART RELATED:...
Organicell

Organicell (BPSR) a Triple Since Easter.

Slowly she turns, step-by-step. $20 million gain in market value. Spurred by FDA Emergency IND's. RELATED: Adding Organicell (BPSR) $0.02 to the Watch List. FDA Approves...
Biotech Stock Review, Exsosomes

Exosomes, Extracellular Vesicles, and the CoronaVirus.

Uploading a Series of Articles on Extracellular Vesicles, Including Potential Effects on the CoronaVirus and ARDS. Article #1: the basics in non-scientific terms from Larry...

Latest article

Jeffrey Gundlach: Reckoning is Coming.

Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm. On 11 November 2020, Gundlach remarked in an interview with...

Who’s the Next Eric Sprott?

To say Eric Sprott has left a legendary mark on the world of mining investment would be an understatement. With a career spanning five...

Perpetua (PPTA) Raises $300 Million.

Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...